NEW YORK (GenomeWeb News) – Signature Genomics Laboratories has received its New York Clinical Laboratory Permit, allowing the firm to receive specimens drawn by clinical laboratories in the state of New York for testing.

The Spokane, Wash.-based firm said today that it is the first laboratory to receive a New York permit to perform microarray-based comparative genomic hybridization. It uses the technology, called SignatureChip, for the genetic evaluation of individuals with unexplained mental retardation and birth defects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.